SHZ · 300529.SZ
Jafron Biomedical Co.,Ltd.
CN¥17.51+CN¥0.11 (+0.63%)
Jafron Biomedical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.1% below the high.
Loading market information…
SHH · 688016.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:29 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shanghai MicroPort Endovascular MedTech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.21% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shanghai MicroPort Endovascular MedTech Co., Ltd.’s forward annual dividend is CN¥2.60 per share, paid semi-annual. The forward yield is 3.04% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shanghai MicroPort Endovascular MedTech Co., Ltd.’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai MicroPort Endovascular MedTech Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Shanghai, PRC, in 2012, Shanghai MicroPort Endovascular MedTech Co., Ltd. specializes in the creation, production, and distribution of medical technologies and products, primarily addressing aortic and peripheral diseases. The company's key offerings include TAA and AAA stent graft systems, as well as different types of balloon catheters such as inflation and PTA dilatation catheters. It operates as a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| -CN¥0.42-134.71% vs estimate |
| CN¥236.76M-55.71% vs estimate |
| Q3 2024 | Oct 29, 2024 | CN¥1.22-18.67% vs estimate | CN¥181.90M-51.63% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥17.51+CN¥0.11 (+0.63%)
Jafron Biomedical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.1% below the high.
CN¥21.04+CN¥0.10 (+0.48%)
China National Accord Medicines Corporation Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.64% below the high.
CN¥14.96+CN¥0.47 (+3.24%)
LBX Pharmacy Chain Joint Stock Company’s quoted price sits in the lower half of its reported 52-week range, 34.87% below the high.
CN¥17.55+CN¥0.10 (+0.57%)
Xiamen Kingdomway Group Company’s quoted price sits in the upper half of its reported 52-week range, 18.45% below the high.
CN¥18.30+CN¥0.17 (+0.94%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.94% below the high.
CN¥21.85+CN¥0.71 (+3.36%)
SonoScape Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 27.74% below the high.
CN¥15.29+CN¥0.30 (+2.0%)
Sansure Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.8% below the high.
CN¥27.12+CN¥0.10 (+0.37%)
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.13% below the high.
